Clinical Investigation of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System

The purpose of this prospective clinical data collection is to document and compare the performance and clinical outcomes between the Maxim® Knee System with Removable Molded Polyethylene Tibia and the Maxim® Knee System with Modular Tibial Bearing as two treatment groups...

Date First Received: December 17, 2007

Last Updated: July 3, 2008

Verified by: Biomet, Inc., July 2008

Clinical Trial Phase: N/A | Start Date: May 2004

Overall Status: Completed

Estimated Enrollment: 200

Brief Summary

Official Title: “A Randomized Data Collection of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System”

The purpose of this prospective clinical data collection is to document and compare the performance and clinical outcomes between the Maxim® Knee System with Removable Molded Polyethylene Tibia and the Maxim® Knee System with Modular Tibial Bearing as two treatment groups.

Study Type: Interventional

Study Design: Treatment, Randomized, Open Label, Parallel Assignment

Intervention(s) in this Clinical Trial

  • Device: Maxim® Knee System with Removable Molded Polyethylene Tibia
    • Used for total knee replacements
  • Device: Regular Maxim® Knee System
    • Used for total knee replacements

Arms, Groups and Cohorts in this Clinical Trial

  • Other: 1
  • Other: 2

Outcome Measures for this Clinical Trial

Primary Measures

  • Knee Society Score, Radiographic information
    • Time Frame: 10 years
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Patients with painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
  • Patients requiring correction of varus, valgus, or posttraumatic deformity.
  • Patients requiring correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure.

Exclusion Criteria:

  • Patients with infection, sepsis, or osteomyelitis.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: Biomet Orthopedics, LLC

Overall Clinical Trial Officials and Contacts

Ken Beres, MD Principal Investigator Biomet Orthopedics, LLC  

Additional Information

Information obtained from ClinicalTrials.gov on September 05, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00579059

Study ID Number: 62-U-007

ClinicalTrials.gov Identifier: NCT00579059

Health Authority: United States: Institutional Review Board

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.